Skip to main content
  • COVID-19
    • COVID-19 vaccines and cancer
      • FAQs
      • FAQs in-language
      • SerOzNET Study
    • COVID-19 information for people affected by cancer
      • Managing your cancer care in the context of COVID-19
      • Looking after your mental wellbeing
      • Canada
      • Ireland
      • UK
      • USA
    • COVID-19 information for children and young people with cancer
    • Cancer Won’t Wait
    • Cancer and COVID-19 - what it means for our Mob
      • COVID-19 vaccines: Information for Aboriginal and Torres Strait Islander people affected by cancer
      • Act early for our Mob's health
    • Guidance for health professionals
      • Diagnosis
      • Treatment
      • Surgery
      • Medical oncology
      • Radiation oncology
      • Primary care
      • Telehealth
      • Clinical trials
      • Follow-up care
      • Supportive and Palliative care
      • Cancer care for cancer patients with COVID-19
      • COVID-19 vaccines and cancer
      • Recovery
    • Research articles
      • Review articles
      • Data articles
      • Recommendations articles
      • Shared experience articles
      • COVID-19 vaccines and cancer articles
    • Cancer care in the time of COVID-19: A conceptual framework
    • Optimal cancer care during the COVID-19 pandemic: the Principles
    • The impact of COVID-19 on cancer services
    • COVID-19 Recovery: Implications for cancer care
      • Expanded use of telehealth
      • Changes to prevention and early detection
      • Virtual multidisciplinary team meetings
      • Modifications to treatment schedules
      • Hypofractionated radiotherapy
      • Oncology hospital in the home
      • Responsive patient support
      • Innovative care and hospital infrastructure models
      • Shared follow-up and survivorship care
      • Supportive and palliative care
      • Cancer research and clinical trials
      • Collaboration in the oncology sector and data sharing
      • Acknowledgements
  • About us
    • Organisational structure
    • Accountability and reporting
      • Annual reports
    • Who we work with
      • Roles & functions
      • Advisory Council
      • Advisory groups
      • Consumer engagement
      • Government cancer control organisations
    • Information publication scheme
      • Information publication scheme plan
      • Freedom of information act
        • The FOI request process
      • FOI disclosure log
    • Reconciliation action plan
    • Employment opportunities
  • News and media
    • News
    • Subscribe to our eNewsletter
  • Contact us
Cancer Australia
Choose Language
  • العربية
  • 简体中文
  • 繁體中文
  • Ελληνικά
  • हिन्दी
  • Italiano
  • 한국어
  • Español
  • Tagalog
  • Tiếng Việt
  • العربية
  • 简体中文
  • 繁體中文
  • Ελληνικά
  • हिन्दी
  • Italiano
  • 한국어
  • Español
  • Tagalog
  • Tiếng Việt
  • العربية
  • 简体中文
  • 繁體中文
  • Ελληνικά
  • हिन्दी
  • Italiano
  • 한국어
  • Español
  • Tagalog
  • Tiếng Việt
  • Home
  • Cancer types
  • Impacted by Cancer
  • Awareness
  • Research
  • Resources
  • Clinicians hub
  • Key initiatives
  • Home
  • Cancer types
    • Bladder cancer
    • Bowel cancer
    • Brain cancer
    • Breast cancer
    • Breast cancer in men
    • Breast cancer in young women
    • Cervical cancer
    • Children’s cancer
    • Endometrial cancer
    • Fallopian cancer
    • Gestational trophoblastic disease
    • Gynaecological cancers
    • Head and neck cancer
    • Kidney cancer
    • Leukaemia
    • Liver cancer
    • Lung cancer
    • Lymphoma
    • Melanoma
    • Mesothelioma cancer
    • Myeloma
    • Neuroendocrine tumours
    • Oesophageal cancer
    • Ovarian cancer
    • Pancreatic cancer
    • Prostate cancer
    • Sarcoma
    • Stomach cancer
    • Testicular cancer
    • Thyroid cancer
    • Unknown primary cancer
    • Uterine sarcoma
    • Vaginal cancer
    • Vulvar cancer
  • Impacted by Cancer
    • What is cancer
    • Physical changes
    • Treatment
    • Keeping healthy
    • Emotions
    • Family and relationships
    • Living with cancer
  • Awareness
    • Your cancer risk
    • Screening
    • Interactive body map
  • Research
    • Cancer Research in Australia
    • Data and statistics
    • Australian Clinical Trials
    • Support for cancer clinical trials
    • Grants and funding
  • Resources
    • Cancer Australia Publications
    • Clinical Practice Guidelines
    • Position statements
    • Resources in other languages
    • Cancer Australia websites
    • Cancer risk online assessment tools
    • Other tools and resources
    • Podcasts
    • Cancer support organisations
    • Glossary
  • Clinicians hub
    • GP guides and resources
    • Guidelines by cancer type
    • Optimal cancer care pathways
    • Working with Aboriginal and Torres Strait Islander people
    • Multidisciplinary care
    • Psychosocial care
    • Follow-up care
    • Family cancer clinics
    • Cancer Learning
    • Consumer engagement
  • Key initiatives
    • For Aboriginal and Torres Strait Islander people
    • Australian Cancer Plan
    • Australian Brain Cancer Mission
    • Jeannie Ferris Award
    • Lung Cancer Screening
    • National Pancreatic Cancer Roadmap
    • Campaigns & events

Kidney cancer

kidney-mm cancer-types/kidney-cancer/overview
    • Home
    • Types
    • Statistics
    • Risk factors
    • Symptoms
    • Screening
    • Diagnosis
    • Treatment
    • Finding support
    • Clinical trials
    • Health professionals
    • Home
    • Types
    • Statistics
    • Risk factors
    • Symptoms
    • Screening
    • Diagnosis
    • Treatment
    • Finding support
    • Clinical trials
    • Health professionals
  1. Home
  2. Treatment
Loading...

Treatment options

  • Printer-friendly version
  • A|A

Treatment and care of people with cancer is usually provided by a team of health professionals, both medical and allied health, called a multidisciplinary team.

Treatment for kidney cancer depends on:

  • the stage of the disease
  • the location of the cancer
  • the severity of symptoms
  • your general health and wishes.

Treatment may involve the following.

Surgery

Treatment for kidney cancer often involves surgery.

As well as removing the cancer, surgery may remove:

  • some of the surrounding kidney tissue – this is a partial nephrectomy
  • the whole kidney – this is a simple nephrectomy
  • the kidney, the adrenal gland that is located on top of the kidney and fatty tissue around the kidney, and sometimes some of the nearby lymph nodes – this is a radical nephrectomy.

The surgery may involve a single large incision in the abdomen or the back, or a number of small ones (laparoscopic surgery).

If there is only one small tumour in a suitable location on the kidney, a partial nephrectomy might be the preferred surgery. This option allows some of the function in the kidney to be retained, compared to a nephrectomy which removes the whole kidney.. However, even if a whole kidney is removed, the remaining kidney usually provides enough function to enable a person to lead a normal, healthy life. If too much kidney tissue is removed, dialysis or a kidney transplant will be needed.

Nearby lymph nodes may also be removed during surgery, especially if they are enlarged.

If the cancer has spread to other parts of the body, surgery may be used to remove these spots (metastases), to attempt to cure the cancer (if there are only a few metastases that can be easily removed) or to relieve pain and other symptoms.

Side effects of surgery for kidney cancer might include pain after the operation, leakage of urine into the abdomen (after partial nephrectomy) or kidney failure (if the remaining kidney does not function well).

Ablation

Removal of tissue (ablation) by means other than surgery is sometimes used to attempt to destroy kidney tumours. Types of ablation include:

  • cryotherapy – use of extreme cold (delivered at the end of a needle probe)
  • radiofrequency ablation – use of high-energy radio waves to heat the tumour (delivered via a needle probe)
  • arterial embolisation – injection of a substance to block blood flow to the affected kidney, to starve the tumour of oxygen and nutrients, causing it to shrink.

Active surveillance

If the kidney tumour is small, doctors may decide to keep a watch on the tumour to see whether it grows. This approach is most likely to be used in elderly or frail people, to avoid the risks associated with surgery.

Chemotherapy

Chemotherapy is not generally used for kidney cancer because kidney cancer cells do not usually respond to traditional chemotherapy medicines.

Radiation therapy

Along with surgery, some people may receive radiation therapy. This is usually done if there is a suspicion that some cancer cells are left behind.

Some kidney cancers do not respond well to radiation, so radiation therapy by itself is more likely to be used in people who need to avoid the risks of surgery. It can also be used to ease the symptoms of kidney cancer. Newer types of radiation therapy might lead to better outcomes in the future.

Targeted therapy

Targeted therapy refers to treatment with medicines that are designed to specifically attack cancer cells without harming normal cells.

Targeted medicines are often used to treat advanced kidney cancers. Although they can shrink or slow the growth of the cancer, none of them have been shown to cure it.

One type of medicine targets a protein that helps tumours form new blood vessels. This type includes the medicines axitinib, bevacizumab, cabozantinib, lenvatinib (used in combination with everolimus) pazopanib, sorafenib and sunitinib

Another type of medicine targets proteins that help cancer cells grow, and inhibits these proteins. This type includes the medicines everolimus, pazopanib, sunitinib and temsirolimus.

Follow-up

After treatment, you will need regular follow-up sessions to check whether the cancer has come back (recurred) or check for side effects of the treatment. These might include physical examinations, blood tests and CT scans.

Advanced and recurrent cancer

If you are diagnosed with stage IV kidney cancer (where the cancer has spread to other parts of the body), the treatment depends on how much the cancer has spread and on your general health. Surgery can be used if the cancer hasn’t spread, or has only spread to one other part of the body, and  appears possible to remove the main tumour and the metastases where it has spread. Even if the cancer has spread to more areas and the metastases cannot be removed, surgery to remove the affected kidney might still be helpful.

If surgery is not possible, targeted therapy is likely to be used.

For advanced kidney cancer, palliative treatments may be used to relieve symptoms such as pain. These treatments include radiation therapy and embolisation.

Kidney cancer can recur (come back) after treatment. The cancer can recur in the kidney or somewhere else in the body, and is classified as local or distant (often called metastatic cancer).

Treatment options for recurrent kidney cancer depends on where it occurs, the treatments that have been used previously and your general health. Options are more surgery, targeted therapy, chemotherapy and palliative treatments.

 
  • Last Updated
  • References
  • Relevant Links
updated: 29 December 2022 - 12:43pm

American Cancer Society (2021). Kidney cancer http://www.cancer.org/cancer/kidneycancer/detailedguide/index.

National Cancer Institute (2020). Renal cell cancer treatment (PDQ®) http://www.cancer.gov/cancertopics/pdq/treatment/renalcell/Patient, patient version.

https://www.cancer.org/cancer/kidney-cancer/treating/targeted-therapy.html

https://www.nps.org.au/australian-prescriber/articles/cabozantinib-for-renal-cell-carcinoma

https://www.cancer.org/cancer/kidney-cancer/treating/targeted-therapy.html

https://www.nps.org.au/australian-prescriber/articles/lenvatinib-for-thyroid-and-renal-cell-cancer

https://www.nps.org.au/medicine-finder/lenvima-capsules

https://au.news.yahoo.com/fotivda-tivozanib-now-approved-treatment-140000073.html

https://www.cancer.org/cancer/kidney-cancer/treating/targeted-therapy.html

https://au.news.yahoo.com/fotivda-tivozanib-now-approved-treatment-140000073.html

American Cancer Society, Kidney cancer
National Cancer Institute (US), Renal cell cancer treatment (PDQ®), patient version
Kidney Health Australia
Australian Cancer Trials

Related information

What is cancer?
What is cancer?

Cancer is a disease of the cells, which are the body’s basic building blocks.

Treatment and side effects
Treatment and side effects

The treatment that your doctors recommend will depend on the type of cancer you have, how advanced it is, and other personal factors.

Living with cancer
Living with cancer

A diagnosis of cancer marks the beginning of a journey full of emotional, psychological, physical and practical challenges.

Life after cancer
Life after cancer

While looking forward to finishing their cancer treatment and getting on with life, for some people, the end of treatment can also be a confusing or worrying time.

A-Z List of Cancer Types

Information on more than 70 types of cancer

  • Bladder cancer
  • Bowel cancer
  • Brain cancer
  • Breast cancer
  • Breast cancer in men
  • Breast cancer in young women
  • Cervical cancer
  • Children's Cancer
  • Endometrial cancer
  • Fallopian cancer
  • Gestational trophoblastic disease
  • Gynaecological cancers
  • Head and neck cancer
  • Kidney cancer
  • Leukaemia
  • Liver cancer
  • Lung cancer
  • Lymphoma
  • Melanoma of the skin
  • Mesothelioma cancer
  • Myeloma
  • Neuroendocrine tumours
  • Oesophageal cancer
  • Ovarian cancer
  • Pancreatic cancer
  • Prostate cancer
  • Sarcoma
  • Stomach cancer
  • Testicular cancer
  • Thyroid cancer
  • Unknown primary
  • Uterine sarcoma
  • Vaginal cancer
  • Vulval cancer

About Cancer Australia

Cancer Australia was established by the Australian Government in 2006 to benefit all Australians affected by cancer, and their families and carers. Cancer Australia aims to reduce the impact of cancer, address disparities and improve outcomes for people affected by cancer by leading and coordinating national, evidence-based interventions across the continuum of care.

If you would like an interpreter to help you understand any information on this website, please call TIS National on 131 450 and ask them to call Cancer Australia on 02 9357 9400. Our business hours are 9am to 5pm, Monday to Friday.

Freecall 1800 624 973
+61 2 9357 9400

Locked Bag 3, Strawberry Hills
NSW 2012

Navigation

  • Cancer types
  • Impacted by Cancer
  • Awareness
  • Research
  • Resources
  • Clinicians hub
  • Key initiatives

Contact us

* Denotes mandatory fields
 

By submitting this form, you accept the Cancer Australia privacy policy.

  • Contact Us
  • Copyright
  • Disclaimer
  • Privacy policy
  • Sitemap
Copyright © 2023 - Cancer Australia